Mirae Asset Global ETFs Holdings’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.4K Buy
5,117
+136
+3% +$2.7K ﹤0.01% 2713
2025
Q4
$97.8K Sell
4,981
-226
-4% -$4.69K ﹤0.01% 2691
2025
Q3
$143K Sell
5,207
-889
-15% -$27.4K ﹤0.01% 2490
2025
Q2
$186K Sell
6,096
-701
-10% -$19.9K ﹤0.01% 2316
2025
Q1
$183K Buy
6,797
+312
+5% +$9.88K ﹤0.01% 2369
2024
Q4
$233K Buy
6,485
+229
+4% +$8.56K ﹤0.01% 2313
2024
Q3
$237K Sell
6,256
-252
-4% -$10.4K ﹤0.01% 2290
2024
Q2
$294K Buy
+6,508
New +$299K ﹤0.01% 2078

Other funds holding USNA

Mirae Asset Global ETFs Holdings's USNA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Usana Health Sciences (USNA) stake by 2.7% in Q1 2026, buying an estimated $2.7K and bringing the position to 5,117 shares worth $89.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Mirae Asset Global ETFs Holdings first reported a position in USNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $294K in Q2 2024. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 5,117 shares of Usana Health Sciences worth $89.4K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 136 Usana Health Sciences shares in Q1 2026, an estimated $2.7K.
  • Usana Health Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2713 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Usana Health Sciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Usana Health Sciences position peaked at $294K in Q2 2024.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.